References
Albright AL, Gilmartin R, Swift D, Krach LE, Ivanhoe CB, McLaughlin JF (2003) Long–term intrathecal baclofen therapy for severe spasticity of cerebral origin. J Neurosurg 98:291–295
Caselli RJ, Smith BE, Osborne D (1995) Primary lateral sclerosis: a neuropsychological study. Neurology 45:2005–2009
Charcot JM (1865) Sclérose des cordons latéraux de la moelle épinière chez une femme hystérique, atteinte de contracture permanente des quatre members. Bull Mém Soc Méd Hôp Paris; second series 2:24–42
Kuipers–Upmeijer J, de Jager AEJ, Hew JM, Snoek JW, van Weerden TW (2001) Primary lateral sclerosis: clinical, neurophysiological, and magnetic resonance findings. J Neurol Neurosurg Psychiatry 71:615–620
Marquardt G, Seifert V (2002) Use of intrathecal baclofen for treatment of spasticity in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 72:275–276
Penn RD, Kroin JS (1984) Intrathecal baclofen alleviates spinal cord spasticity. Lancet 1:1078 (Letter)
Pringle CE, Hudson AJ, Munoz DG, Kieman JA, Brown WF, Ebers GC (1992) Primary lateral sclerosis. Clinical features, neuropathology and diagnosis criteria. Brain 115:495–520
Sampson FC, Hayward A, Evans G, Morton R, Collett B (2002) Functional benefits and cost/benefit analysis of continuous intrathecal baclofen infusion for the management of severe spasticity. J Neurosurg 96:1052–1057
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Buzetti Milano, J., Coelho Neto, M., Hunhevicz, S.C. et al. Intrathecal baclofen for spasticity in primary lateral sclerosis. J Neurol 252, 740–741 (2005). https://doi.org/10.1007/s00415-005-0746-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-005-0746-7